| RS116142981 |
FKBP10
|
Health Risk |
Conflicting classifications of pathogenicity |
Osteogenesis imperfecta, FKBP10-related disorder |
| RS1161436837 |
EPG5
|
Health Risk |
Pathogenic |
Vici syndrome, Vici syndrome |
| RS1161451203 |
MKS1
|
Health Risk |
Pathogenic |
Meckel-Gruber syndrome, Joubert syndrome |
| RS1161453292 |
EYS
|
Health Risk |
Conflicting classifications of pathogenicity |
Retinal dystrophy, Retinitis pigmentosa 25 |
| RS1161458067 |
MPDZ
|
Health Risk |
Likely pathogenic |
Hydrocephalus, nonsyndromic |
| RS1161473997 |
KIT
|
Health Risk |
Pathogenic |
Gastrointestinal stromal tumor, Gastrointestinal stromal tumor |
| RS116147541 |
MYO16
|
Health Risk |
Conflicting classifications of pathogenicity |
— |
| RS1161477501 |
CYB5R3
|
Health Risk |
Likely pathogenic |
Deficiency of cytochrome-b5 reductase, Deficiency of cytochrome-b5 reductase |
| RS1161478770 |
NEB
|
Health Risk |
Pathogenic/Likely pathogenic |
Nemaline myopathy, Nemaline myopathy 2 |
| RS116148064 |
PDSS1
|
Health Risk |
Conflicting classifications of pathogenicity |
— |
| RS116148295 |
ANK1
|
Health Risk |
Conflicting classifications of pathogenicity |
Spherocytosis, Hereditary spherocytosis type 1 |
| RS116148705 |
ARHGEF18
|
Health Risk |
Conflicting classifications of pathogenicity |
Inborn genetic diseases, Inborn genetic diseases |
| RS1161487989 |
COL4A4
|
Health Risk |
Likely pathogenic |
— |
| RS1161495077 |
ACADVL
|
Health Risk |
Conflicting classifications of pathogenicity |
Very long chain acyl-CoA dehydrogenase deficiency, Very long chain acyl-CoA dehydrogenase deficiency |
| RS1161498711 |
STAG3
|
Health Risk |
Likely pathogenic |
Spermatogenesis maturation arrest, Non-obstructive azoospermia |
| RS1161512784 |
PC
|
Health Risk |
Conflicting classifications of pathogenicity |
Pyruvate carboxylase deficiency, Pyruvate carboxylase deficiency |
| RS1161525517 |
SKIC3
|
Health Risk |
Pathogenic |
— |
| RS1161530285 |
ABCC2
|
Health Risk |
Pathogenic |
— |
| RS116153163 |
COG7
|
Health Risk |
Conflicting classifications of pathogenicity |
COG7 congenital disorder of glycosylation, COG7 congenital disorder of glycosylation |
| RS1161535903 |
POGLUT1
|
Health Risk |
Pathogenic |
— |
| RS1161550353 |
ABCA12
|
Health Risk |
Pathogenic |
— |
| RS1161552095 |
GBA1
|
Health Risk |
Likely pathogenic |
GBA1-related disorder, GBA1-related disorder |
| RS1161553940 |
FIG4
|
Health Risk |
Pathogenic |
Charcot-Marie-Tooth disease type 4, Charcot-Marie-Tooth disease type 4 |
| RS1161562868 |
FAT2
|
Health Risk |
Conflicting classifications of pathogenicity |
— |
| RS1161576814 |
CR2
|
Health Risk |
Pathogenic |
Immunodeficiency, common variable |
| RS116158771 |
PALLD
|
Health Risk |
Conflicting classifications of pathogenicity |
Pancreatic cancer, susceptibility to |
| RS1161589003 |
VPS13B
|
Health Risk |
Pathogenic/Likely pathogenic |
Cohen syndrome, Cohen syndrome |
| RS1161604514 |
ATP6V1B1
|
Health Risk |
Pathogenic/Likely pathogenic |
Renal tubular acidosis with progressive nerve deafness, Renal tubular acidosis with progressive nerve deafness |
| RS1161610345 |
CSPP1
|
Health Risk |
Likely pathogenic |
Joubert syndrome 21, Joubert syndrome 21 |
| RS116162724 |
POLE
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary cancer-predisposing syndrome, Facial dysmorphism-immunodeficiency-livedo-short stature syndrome |
| RS1161636527 |
INPP5E
|
Health Risk |
Conflicting classifications of pathogenicity |
Joubert syndrome 1, INPP5E-related disorder |
| RS116164106 |
LARGE1
|
Health Risk |
Conflicting classifications of pathogenicity |
Muscular dystrophy, Muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies) |
| RS1161647781 |
SPTA1
|
Health Risk |
Pathogenic/Likely pathogenic |
— |
| RS1161652737 |
USH2A
|
Health Risk |
Likely pathogenic |
Ear malformation, Ear malformation |
| RS1161689441 |
SMARCA2
|
Health Risk |
Conflicting classifications of pathogenicity |
Inborn genetic diseases, Inborn genetic diseases |
| RS1161693014 |
CSF1R
|
Health Risk |
Conflicting classifications of pathogenicity |
— |
| RS116171274 |
CYP7B1
|
Health Risk |
Pathogenic/Likely pathogenic |
Hereditary spastic paraplegia 5A, Spastic paraplegia |
| RS1161720919 |
NPHS1
|
Health Risk |
Pathogenic |
Finnish congenital nephrotic syndrome, Finnish congenital nephrotic syndrome |
| RS1161735211 |
TTN
|
Health Risk |
Pathogenic |
Primary dilated cardiomyopathy, Primary dilated cardiomyopathy |
| RS1161738395 |
LMX1B
|
Health Risk |
Likely pathogenic |
— |
| RS116174472 |
NPHP3
|
Health Risk |
Conflicting classifications of pathogenicity |
NPHP3-related Meckel-like syndrome, Nephronophthisis |
| RS1161756211 |
QRICH2
|
Health Risk |
Likely pathogenic |
QRICH2-related disorder, QRICH2-related disorder |
| RS1161768105 |
GRIN1
|
Health Risk |
Pathogenic/Likely pathogenic |
Neurodevelopmental disorder with or without hyperkinetic movements and seizures, autosomal dominant |
| RS1161787867 |
BLM
|
Health Risk |
Conflicting classifications of pathogenicity |
Bloom syndrome, Hereditary cancer-predisposing syndrome |
| RS1161799599 |
COL4A3
|
Health Risk |
Pathogenic |
— |
| RS116180923 |
PYGM
|
Health Risk |
Conflicting classifications of pathogenicity |
Glycogen storage disease, type V |
| RS116181849 |
FAM20C
|
Health Risk |
Conflicting classifications of pathogenicity |
Lethal osteosclerotic bone dysplasia, Lethal osteosclerotic bone dysplasia |
| RS1161843319 |
ACTN2
|
Health Risk |
Conflicting classifications of pathogenicity |
Dilated cardiomyopathy 1AA, Primary familial hypertrophic cardiomyopathy |
| RS1161850370 |
INPPL1
|
Health Risk |
Likely pathogenic |
— |
| RS1161862851 |
KCNT1
|
Health Risk |
Conflicting classifications of pathogenicity |
Developmental and epileptic encephalopathy, 14 |
| RS1161880335 |
TRPM4
|
Health Risk |
Conflicting classifications of pathogenicity |
Cardiomyopathy, Cardiovascular phenotype |
| RS1161907698 |
FOCAD
|
Health Risk |
Pathogenic |
Liver disease, severe congenital |
| RS1161918267 |
FANCB
|
Health Risk |
Pathogenic |
Fanconi anemia complementation group B, Fanconi anemia complementation group B |
| RS116192442 |
PNKP
|
Health Risk |
Conflicting classifications of pathogenicity |
Developmental and epileptic encephalopathy, 12 |
| RS1161929108 |
RYR1
|
Health Risk |
Likely pathogenic |
RYR1-related disorder, RYR1-related disorder |
| RS116193143 |
DYNC2I1
|
Health Risk |
Conflicting classifications of pathogenicity |
Short-rib thoracic dysplasia 8 with or without polydactyly, Inborn genetic diseases |
| RS1161932777 |
MRPS34
|
Health Risk |
Pathogenic |
Leigh syndrome, Combined oxidative phosphorylation deficiency 32 |
| RS1161951509 |
MYO15A
|
Health Risk |
Likely pathogenic |
— |
| RS1161972119 |
MUTYH
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary cancer-predisposing syndrome, Familial adenomatous polyposis 2 |
| RS116197349 |
PRICKLE1
|
Health Risk |
Conflicting classifications of pathogenicity |
Epilepsy, progressive myoclonic |
| RS116198081 |
CC2D2A
|
Health Risk |
Conflicting classifications of pathogenicity |
Meckel syndrome, type 6 |
| RS1161995349 |
NPHP4
|
Health Risk |
Conflicting classifications of pathogenicity |
Nephronophthisis, Nephronophthisis |
| RS1162015461 |
DDX41
|
Health Risk |
Conflicting classifications of pathogenicity |
Inborn genetic diseases, Inborn genetic diseases |
| RS116201949 |
MBD1
|
Health Risk |
Conflicting classifications of pathogenicity |
— |
| RS1162037663 |
TANGO2
|
Health Risk |
Pathogenic/Likely pathogenic |
Recurrent metabolic encephalomyopathic crises-rhabdomyolysis-cardiac arrhythmia-intellectual disability syndrome, Recurrent metabolic encephalomyopathic crises-rhabdomyolysis-cardiac arrhythmia-intellectual disability syndrome |
| RS116204385 |
DYSF
|
Health Risk |
Conflicting classifications of pathogenicity |
Neuromuscular disease caused by qualitative or quantitative defects of dysferlin, Autosomal recessive limb-girdle muscular dystrophy type 2B |
| RS116204707 |
ARPC1B
|
Health Risk |
Pathogenic |
— |
| RS1162048721 |
F9
|
Health Risk |
Likely pathogenic |
Thrombophilia, X-linked |
| RS1162054356 |
KBTBD13
|
Health Risk |
Conflicting classifications of pathogenicity |
Nemaline myopathy 6, Nemaline myopathy 6 |
| RS116207524 |
MBD5
|
Health Risk |
Conflicting classifications of pathogenicity |
Intellectual disability, autosomal dominant 1 |
| RS116211118 |
CD151
|
Health Risk |
Conflicting classifications of pathogenicity |
— |
| RS116214586 |
CACNA2D4
|
Health Risk |
Conflicting classifications of pathogenicity |
Retinal cone dystrophy 4, CACNA2D4-related disorder |
| RS116214830 |
SGCB
|
Health Risk |
Conflicting classifications of pathogenicity |
Autosomal recessive limb-girdle muscular dystrophy type 2E, Primary dilated cardiomyopathy |
| RS116215208 |
MYO6
|
Health Risk |
Conflicting classifications of pathogenicity |
Autosomal recessive nonsyndromic hearing loss 37, Autosomal dominant nonsyndromic hearing loss 22 |
| RS1162164452 |
MYO15A
|
Health Risk |
Conflicting classifications of pathogenicity |
Inborn genetic diseases, Inborn genetic diseases |
| RS116216460 |
KRT9
|
Health Risk |
Conflicting classifications of pathogenicity |
Palmoplantar keratoderma, epidermolytic |
| RS1162166308 |
ADGRV1
|
Health Risk |
Pathogenic |
— |
| RS116218572 |
LAMB3
|
Health Risk |
Conflicting classifications of pathogenicity |
Inborn genetic diseases, Inborn genetic diseases |
| RS1162193591 |
LGI1
|
Health Risk |
Conflicting classifications of pathogenicity |
Autosomal dominant epilepsy with auditory features, Inborn genetic diseases |
| RS116219738 |
PALLD
|
Health Risk |
Conflicting classifications of pathogenicity |
Pancreatic cancer, susceptibility to |
| RS1162214541 |
ABCA4
|
Health Risk |
Pathogenic/Likely pathogenic |
Retinal dystrophy, Autosomal recessive ABCA4-related disorders |
| RS1162224576 |
MECR
|
Health Risk |
Pathogenic |
— |
| RS1162236403 |
EGFR
|
Health Risk |
Conflicting classifications of pathogenicity |
EGFR-related lung cancer, Hereditary cancer-predisposing syndrome |
| RS116225248 |
RELN
|
Health Risk |
Conflicting classifications of pathogenicity |
Familial temporal lobe epilepsy 7, Norman-Roberts syndrome |
| RS116228809 |
MYO7A
|
Health Risk |
Conflicting classifications of pathogenicity |
Autosomal recessive nonsyndromic hearing loss 2, Usher syndrome type 1 |
| RS116229331 |
UNC13D
|
Health Risk |
Conflicting classifications of pathogenicity |
Familial hemophagocytic lymphohistiocytosis 3, Autoinflammatory syndrome |
| RS1162296750 |
MYO15A
|
Health Risk |
Pathogenic/Likely pathogenic |
Rare genetic deafness, Rare genetic deafness |
| RS116229809 |
UQCRQ
|
Health Risk |
Conflicting classifications of pathogenicity |
Mitochondrial complex III deficiency nuclear type 4, Mitochondrial complex III deficiency nuclear type 4 |
| RS11623 |
GALC
|
Health Risk |
Likely pathogenic |
Galactosylceramide beta-galactosidase deficiency, Galactosylceramide beta-galactosidase deficiency |
| RS1162305984 |
USH2A
|
Health Risk |
Likely pathogenic |
Retinitis pigmentosa 39, Usher syndrome type 2A |
| RS1162306056 |
KCNQ3
|
Health Risk |
Pathogenic |
Benign neonatal seizures, Seizures |
| RS1162309498 |
MYRF
|
Health Risk |
Likely pathogenic |
Cardiac-urogenital syndrome, Cardiac-urogenital syndrome |
| RS1162316051 |
AIRE
|
Health Risk |
Pathogenic |
Polyglandular autoimmune syndrome, type 1 |
| RS116232047 |
TLR2
|
Health Risk |
Conflicting classifications of pathogenicity |
TLR2-related disorder, Colorectal cancer |
| RS1162322343 |
SCN2A
|
Health Risk |
Conflicting classifications of pathogenicity |
Seizures, benign familial infantile |
| RS116233118 |
UROD
|
Health Risk |
Conflicting classifications of pathogenicity |
Familial porphyria cutanea tarda, UROD-related disorder |
| RS1162344514 |
DCLRE1C
|
Health Risk |
Pathogenic |
Severe combined immunodeficiency due to DCLRE1C deficiency, Histiocytic medullary reticulosis |
| RS116235450 |
KCNJ10
|
Health Risk |
Conflicting classifications of pathogenicity |
Autosomal recessive nonsyndromic hearing loss 4, EAST syndrome |
| RS1162371435 |
CEBPA
|
Health Risk |
Conflicting classifications of pathogenicity |
Acute myeloid leukemia, Inborn genetic diseases |
| RS116237993 |
CPLANE1
|
Health Risk |
Conflicting classifications of pathogenicity |
— |